HKBU develops world-first metal-based probes for detection of dopamine receptors, a cancer biomarker

Dopamine is an important neurotransmitter in the central nervous system of the human body and plays important roles in motivation, cognition and motor control. While dopamine receptors have long been implicated in neurodegenerative diseases, such as Parkinson's disease, recent evidence has linked dopamine receptors also with various cancers, including lung, breast and colon cancers. Traditional detection methods for dopamine receptors include the enzyme-linked immunosorbent assay (ELISA). However, such methods suffer from high cost, incompatibility with living systems, and are not suitable for the real-time study of the biological role of dopamine receptors.

The metal-based probes developed by the team are able to selectively bind to dopamine receptors on lung cancer cells, "lighting up" the cells and making them visible to the naked eye. The probes enable the monitoring and tracking of dopamine receptors in living cells in a real-time and in a non-invasive fashion. Moreover, the experiment results demonstrated that the imaging colour intensity was correlates with the expression levels of dopamine receptors on cancer cells. These probes could therefore both help to elucidate the role of dopamine receptors in the pathogenesis of cancers and offer a potential diagnostic tool for the early screening of cancers. Importantly, the metal-based probes avoid the problems of poor photostability and photobleaching that limit conventional fluorescent imaging dyes.

The research project entitled "Cell imaging of dopamine receptor using agonist labeling iridium(III) complex" was led by Dr Edmond Ma of HKBU together with Professor Leung Chung-hang of the Institute of Chinese Medical Sciences, University of Macau. Other collaborators of the project included researchers from the School of Chinese Medicine of HKBU, the City University of Hong Kong, University of Florida, USA, and Hunan University, China.

Dr Ma said, "Early detection is crucial for improving the survival rate of hard-to-treat cancers such as lung cancer, which is associated with dopamine receptor expression. For instance, data from the American Cancer Society shows that patients with early stage non-small cell lung cancer (NSCLC) have a five-year survival rate of about 92%, but this drops to only about 36% when the cancer has progressed to an advanced stage. We therefore believe that these dopamine receptor probes show great promise for the development of molecular diagnostic tools for the early detection of cancer."

Dr Ma added that because the probes could successfully track the internalisation process of dopamine receptors in cells, they also represent powerful tools for studying the role of dopamine receptors in the pathogenesis of cancer.

Media enquiries: Tina Ng of the Communication and Public Relations Office (+852 3411 5262) or Dr Edmond Ma of the Department of Chemistry (+852 3411 7075)

Topic: Press release summarySectors: Chemicals, Nanotechnology, BioTech, HealthCare^[1][2][3][4] http://www.acnnewswire.com From the Asia Corporate News Network

Copyright © 2018 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

References

1. ^{^} Chemicals (www.acnnewswire.com)
2. ^{^} Nanotechnology (www.acnnewswire.com)
3. ^{^} BioTech (www.acnnewswire.com)
4. ^{^} HealthCare (www.acnnewswire.com)